| Bio-Reference Laboratories, Inc. Reports Record Quarterly Revenues (Business Wire) ELMWOOD PARK, N.J.----Bio-Reference Laboratories, Inc. released its second quarter, fiscal year 2010 earnings today for the three months ending April 30. The Company recorded current quarter revenues of $110,447, the best ever quarter in corporate history and an increase of 27% over the $87,183 recorded in the second quarter, fiscal year 2009. us.rd.yahoo.com |
Roche Diabetes Drug Faces Delay Roche said new safety concerns about its diabetes drug taspoglutide require deeper monitoring of patients' response to the medicine, which will push back an expected regulatory filing. online.wsj.com |
LabCorp Establishes Global Clinical Trials Collaboration with Clearstone Central Labs (Business Wire) BURLINGTON, N.C.----Laboratory Corporation of America® Holdings announced today a collaboration between Esoterix Clinical Trials Services, a division of LabCorp, and Clearstone Central Laboratories, a global central laboratory specializing in drug development and pharmaceutical services. us.rd.yahoo.com |
Glaxo Taps Banker as Finance Chief GlaxoSmithKline chose Simon Dingemans, a Goldman Sachs M&A specialist, to be its next chief financial officer. online.wsj.com |
PPD Significantly Expands Network of Investigators in Northern India [Business Wire] - PPD, Inc. today announced it has established an agreement with the Himalayan Institute and Hospital Trust , a large teaching hospital in northern India, to create a large investigator site to expand its network of highly qualified investigators in a region that has become increasingly important for conducting global clinical trials. us.rd.yahoo.com |